Metastasis is the primary cause of death in lung cancer patients. However, until now, effective drugs and intervention strategies for treating lung cancer metastasis have been lacking. This hypothesis focuses on circulating tumour cells (CTCs) to develop a new antimetastatic therapeutic strategy for lung cancer. Here, we outline the role of CTCs in tumour metastasis and their functional effects during the treatment of lung cancer patients. Additionally, we hypothesized the possibility of CTCs as a novel biomarker and therapeutic target in preventing and treating metastasis in patients with early-stage lung cancer. We hope that the realization of this hypothesis will improve the overall survival of lung cancer.
CITATION STYLE
Que, Z., & Tian, J. (2022). New strategy for antimetastatic treatment of lung cancer: a hypothesis based on circulating tumour cells. Cancer Cell International, 22(1). https://doi.org/10.1186/s12935-022-02782-w
Mendeley helps you to discover research relevant for your work.